Siavash S. Asgari, MS, Pramod Bonde, MD 

Slides:



Advertisements
Similar presentations
Axial and centrifugal continuous-flow rotary pumps: A translation from pump mechanics to clinical practice  Nader Moazami, MD, Kiyotaka Fukamachi, MD,
Advertisements

Opening and closing kinematics of fresh and calcified aortic valve prostheses: An in vitro study  Farhad Bakhtiary, MD, Omer Dzemali, MD, Ulrich Steinseiffer,
Zain Khalpey, MD, PhD, MRCS (Eng), Nicole Sydow, MD, Marvin J
Long-term mechanical circulatory support: A new disease state?
Creating an ideal “off-test mode” for rotary left ventricular assist devices: Establishing a safe and appropriate weaning protocol after myocardial recovery 
James A. Magovern, David M. Lasorda 
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data  Deborah Morley, PhD, Kenneth.
The RECOVER I: A multicenter prospective study of Impella 5
Association of device surface and biomaterials with immunologic sensitization after mechanical support  Isaac George, MD, Patrick Colley, BS, Mark J.
Linear end-systolic pressure-volume relationship during pulsatile left ventricular bypass represents native heart function  Osamu Kawaguchi, MD, John.
Martin Strueber, MD, Anna L
A tale of two centrifugal left ventricular assist devices
Three-dimensional magnetic resonance flow analysis in a ventricular assist device  Michael Markl, PhD, Christoph Benk, MS, Dominik Klausmann, MS, Aurelien.
Direct aortic transcatheter aortic valve implantation for pure aortic valve regurgitation after implantation of a left ventricular assist device  René.
Off-pump implantation of the HeartMate 3 left ventricular assist device through a bilateral thoracotomy approach  Evgenij V. Potapov, MD, PhD, Marian.
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
High-speed visualization of disturbed pathlines in axial flow ventricular assist device under pulsatile conditions  Fang Yang, PhD, Robert L. Kormos,
Weaning of rotary blood pump recipients after myocardial recovery: a computer study of changes in cardiac energetics  Heinrich Schima, PhD, Michael Vollkron,
Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices  Ranjit John, MD, Kenneth Liao,
Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.
Alternation of left ventricular load by a continuous-flow left ventricular assist device with a native heart load control system in a chronic heart failure.
Form ever follows function
Advances and Future Directions for Mechanical Circulatory Support
In vitro hemodynamic characterization of HeartMate II at 6000 rpm: Implications for weaning and recovery  Gengo Sunagawa, MD, Nicole Byram, BS, Jamshid.
Intra-aortic balloon pump therapy negatively affects flow through a continuous-flow left ventricular assist device  Dipanjan Banerjee, MD, MS, Chun Choi,
The engineer and the clinician: Understanding the work output and troubleshooting of the HeartMate II rotary flow pump  W. Scott Arnold, MD, Kevin Bourque,
Mechanical circulatory assist device development at the Texas Heart Institute: A personal perspective  O.H. Frazier, MD  The Journal of Thoracic and Cardiovascular.
Heart Mate Pump 2 LVAD Patient Stories
Mano J. Thubrikar, PhD, Francis Robicsek, MD, Brett L. Fowler, BS 
Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to.
Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation  Jooeun Kang, BA, David M. Zhang, David.
A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients  Khanh Nguyen, MD  The Journal.
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome  Kevin G. Soucy, PhD, Steven.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Adverse events in contemporary continuous-flow left ventricular assist devices: A multi- institutional comparison shows significant differences  John M.
Sumanth Kidambi, MD, Yasuhiro Shudo, MD, PhD, Michael D. Dake, MD, Y
Left ventricular assist device therapy in a patient with hearing and speech disabilities  Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
Do we need a bibliometrician to know which way the wind is blowing?
Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement 
Minimally invasive off-pump implantation of HeartMate 3 left ventricular assist device  Diyar Saeed, MD, PhD, Stephan Sixt, MD, PhD, Alexander Albert,
Guruprasad A. Giridharan, PhD, Steven C
Martin Strueber, MD, Jan D
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin?  Francesco.
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J
Prognosis and “granularity”: Building on staging foundations?
Graft flow assessment using a transit time flow meter in fractional flow reserve–guided coronary artery bypass surgery  Kentaro Honda, MD, Yoshitaka Okamura,
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Use of polytetrafluoroethylene vascular graft to cover the kinking protector of left ventricular assist device facilitates later pump exchange  Evgenij.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices  Forum Kamdar, MD, Ranjit John,
Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices  Simon.
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Preoperative PFTs: The answer is blowing in the wind
The evolution of cardiothoracic critical care
Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets  Juan A. Crestanello, MD  The Journal of Thoracic.
Did you like Terminator 3 better than Terminator 2
Investigation of hemodynamics in an in vitro system simulating left ventricular support through the right subclavian artery using 4-dimensional flow magnetic.
Hari R. Mallidi, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device.
Presentation transcript:

Implantable physiologic controller for left ventricular assist devices with telemetry capability  Siavash S. Asgari, MS, Pramod Bonde, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 147, Issue 1, Pages 192-202 (January 2014) DOI: 10.1016/j.jtcvs.2013.09.012 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, The developed UMC-Physio coupled with the FREE-D receiver coil to wirelessly obtain power and run an LVAD pump. B, The external graphical user interface embedded in a smartphone. This platform displays and controls an LVAD pump by wireless communication or Internet access. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 In vitro test setup where an LVAD pump is placed in an MCL. The pressure and flow are measured by the corresponding sensors. HMII, HeartMate II; HVAD, HeartWare Ventricular Assist Device; LVAD, left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 The result of our in vitro testing with the HeartMate II (Thoratec Co, Pleasanton, Calif) pump. Most of these equations are related to a specific MCL. A, Our controller adapts to changes in heart rate to create the corresponding mean LVAD flow. The degree of pulsatility also changes the mean flow. The linear regression for this model is as follows: Mean LVAD Flow (L/min) = 0.031333 · Heart Rate (beats/min) + 0.00024089 · ΔRPM (rpms) + 2.38056. B, A 10% increase in fraction of systole increases the mean flow in our system by 0.29 L/min; therefore, more flexibility is added to adapt to the patient's everyday life. This relationship is modeled as follows: Mean LVAD Flow (L/min) = 0.02486 · Heart Rate (beats/min) + 0.02934 · Fraction of Systole (%) + 1.8883. C to F, The UMC-Physio changes the systolic and diastolic pressures by increases or decreases in the heart rate. The following equations represent the estimated systolic and diastolic pressures: Systolic Pressure (mm Hg) = 0.44014 · Heart Rate (beats/min) + 0.01041 · ΔRPM (rpms) + 2.02963 Diastolic Pressure (mm Hg) = 0.41806 · Heart Rate (beats/min) + 0.00042593 · ΔRPM (rpms) + 4.85185. G, Increments in ΔRPM generate more pulsatility. H, For 2 watts of power, the UMC-Physio produces 5.5 L/min of flow, whereas the HeartMate II controller can create only 3.8 L/min; therefore, our controller is on average more efficient by 17.54%. This result is good evidence for how pump controller optimization and precise control can contribute to the efficiency of an LVAD. The efficiency is estimated by the following: Efficiency (%) = 0.08309 · Flow3 + 1.897 · Flow2 + 13.907 · Flow (L/min) − 15.6778. bmp, Beats/min; LVAD, left ventricular assist device; ΔRPM, difference between systolic and diastolic pump speeds; UMC-Physio, ultra-compact implantable physiologic controller. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 The results of the in vitro testing with the HeartWare Ventricular Assist Device (HeartWare Inc, Framingham, Mass) pump. The results are related to our MCL. A, The UMC-Physio increases the mean flow of the centrifugal pump by 0.22 L/min with 10 beats/min in the heart rate. The linear regression model for this graph is Mean LVAD Flow (L/min) = 0.0226 · Heart Rate (beats/min) + 0.000638222 · ΔRPM (rpms) + 3.7245. B, Confirms that 10% increase in fraction of systole linearly increases the mean LVAD flow by 0.2 L/min. This formula explains this linear regression: Mean LVAD Flow (L/min) = 0.0046 · Heart Rate (beats/min) + 0.0205 · Fraction of Systole (%) + 4.09312. C to F, Heart rates up to 80 beats/min will increase the systolic and diastolic pressures produced by our controller. The systolic and diastolic pressures can be estimated by the following formulas: Systolic Pressure (mm Hg) = 0.50067 · Heart Rate (beats/min) + 0.02364 · ΔRPM (rpms) + 31.9855 Diastolic Pressure (mm Hg) = 0.26817 · Heart Rate (beats/min) + 0.00188 · ΔRPM (rpms) + 32.085. G, Pulse pressure can be easily controlled by our system; the linear regression is modeled as Pulse Pressure (mm Hg) = 0.2325 · Heart Rate (beats/min) + 0.02176 · ΔRPM (rpms) − 0.14. H, Proves that our controller is also more efficient than the HeartWare Ventricular Assist Device controller. The descriptive statistics indicate that our controller is more efficient by a mean of 35.49%. Efficiency is modeled as follows: Efficiency (%) = 2.648 · Flow2 − 32.630 · Flow (L/min) + 132.964. bmp, Beats/min; LVAD, left ventricular assist device; ΔRPM, difference between systolic and diastolic pump speeds; UMC-Physio, ultra-compact implantable physiologic controller. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Representative demonstration of the power consumption and speed of a HeartWare Ventricular Assist Device pump in one of our in vivo experiments. The consistent and smooth pump speed indicates how our control adapts to the sudden changes of our wireless power delivery. In addition, it displays the EMF noise-free telemetry data. The temperature of the implanted unit also is graphed to illustrate there was no temperature increase in the unit that might affect the surrounding tissues. HVAD, HeartWare Ventricular Assist Device; RPM, revolutions per minute; UMC-Physio, ultra-compact implantable physiologic controller. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Appendix Figure 1 A-C, The step by step movement of a rotor in a simple 2-phase brushless motor. When current passes through the electromagnets (wire winding around an iron core), they will be magnetized and their poles will attract the opposite poles of the permanent magnet (rotor). Once the direction of the current is reversed, the poles of the electromagnets will be reversed and, therefore, like poles of the electromagnet and rotor will be aligned. This would create a force that causes the rotor to move. The rotor moves until its poles are facing the opposite poles of the electromagnet. By alternating the direction of the current, we can therefore rotate the rotor. D, A simplified version of a 3-phase brushless direct current motor that is a basis of a left ventricular assist device. E, The schematic of the electronic switches that control the direction of the current that passes through the electromagnets of a left ventricular assist device. The schematic view of how electromagnets are wound is shown on the right side. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 192-202DOI: (10.1016/j.jtcvs.2013.09.012) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions